Envoy Medical (COCH) Net Equity Issued and Repurchased (2024 - 2026)

Envoy Medical (COCH) posted Net Equity Issued and Repurchased of $30.0 million for Q1 2026, up 14184.29% sequentially from $210000.0 in Q3 2025.

Envoy Medical (COCH) Net Equity Issued and Repurchased (2024 - 2026) Analysis & Trends

Envoy Medical has reported Net Equity Issued and Repurchased for 3 years, with the latest figure at $30.0 million in Q1 2026.

Quarterly Net Equity Issued and Repurchased changed N/A year-over-year to $30.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $30.2 million (changed N/A YoY) and the FY2025 annual result came in at $414000.0, changed N/A from the prior year.
Net Equity Issued and Repurchased climbed to $30.0 million in Q1 2026 per COCH's latest filing, from $210000.0 in the prior quarter.
Over five years, Net Equity Issued and Repurchased peaked at $30.0 million in Q1 2026 and troughed at $210000.0 in Q3 2025.
A 3-year average of $10.6 million and a median of $1.7 million in 2024 frame the typical range for Net Equity Issued and Repurchased.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Net Equity Issued and Repurchased (Qtr)
1	Abbott Laboratories	198.70 Bn	193.10 Bn	7.27 Bn	-
2	Stryker	125.85 Bn	122.37 Bn	4.50 Bn	-
3	Medtronic	118.44 Bn	109.22 Bn	6.41 Bn	97.00 Mn
4	Boston Scientific	72.64 Bn	72.10 Bn	3.85 Bn	-
5	Edwards Lifesciences	51.94 Bn	47.69 Bn	1.35 Bn	-
6	Dexcom	34.48 Bn	32.53 Bn	830.00 Mn	-
7	GE HealthCare Technologies	33.60 Bn	31.49 Bn	2.18 Bn	-
8	Koninklijke Philips	26.30 Bn	22.98 Bn	4.55 Bn	-
9	Steris	23.00 Bn	22.52 Bn	684.20 Mn	-
10	Envoy Medical	77.82 Mn	58.14 Mn	-227,000.00	-

Download Data